Nanotechnology and Drug Delivery Systems

Nanotechnology has introduced transformative possibilities in cancer drug delivery systems. Nanocarriers, such as liposomes and polymer-based nanoparticles, enhance the precision and efficiency of delivering chemotherapeutic agents to tumor sites. These systems improve drug solubility, stability, and bioavailability while minimizing side effects by sparing healthy tissues. Advanced nanotechnology platforms also enable targeted delivery through ligand-receptor interactions, ensuring drugs reach specific cancer cells. Innovations in this field continue to refine treatment outcomes, offering a promising avenue for overcoming traditional chemotherapy limitations.